About Edaravone
Class: | Neuroprotective agent
Use: | Treatment of amyotrophic lateral sclerosis (ALS)
Adult dose: | 60 mg (30 mg/100 mL) administered as an intravenous infusion over 60 minutes, given daily for 14 days, followed by a 14-day drug-free period; this cycle can be repeated.
Pediatric dose: | Safety and efficacy have not been established in pediatric patients; not recommended for use in children.
Side effects: | Common side effects include bruising, gait disturbance, headache, and infusion si
Drug Class
Neuroprotective agent
Uses & Indications
Treatment of amyotrophic lateral sclerosis (ALS)
Storage Requirements
Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from light; do not freeze.
Manufacturer & Packaging
Manufacturer: Mitsubishi Tanabe Pharma GmbH, Japan
Package Size
2's
Price & Supplier
Price in UAE: AED 2004.51
Dosage Information
Adult Dose
60 mg (30 mg/100 mL) administered as an intravenous infusion over 60 minutes, given daily for 14 days, followed by a 14-day drug-free period; this cycle can be repeated.
Pediatric Dose
Safety and efficacy have not been established in pediatric patients; not recommended for use in children.
Side Effects
Common side effects include bruising, gait disturbance, headache, and infusion site reactions (e.g., pain, redness, swelling).
Contraindications & Precautions
Hypersensitivity to edaravone or any component of the formulation; caution in patients with renal impairment.
Important Warnings
Risk of serious allergic reactions; monitor for signs of hypersensitivity during and after infusion. Use with caution in patients with renal impairment; efficacy and safety in patients with severe renal impairment have not been established.
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.